Skip to main content
Type at least 3 characters

1,971 articles

articles

Original Research

Published on 27 Nov 2024

Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1

in Thoracic Oncology

  • Zachary D. Wallen
  • Mary K. Nesline
  • Marni Tierno
  • Alison Roos
  • Erica Schnettler
  • Hatim Husain
  • Pratheesh Sathyan
  • Brian Caveney
  • Marcia Eisenberg
  • Eric A. Severson
Frontiers in Oncology
doi 10.3389/fonc.2024.1473327
  • 4,537 views
  • 1 citation

Original Research

Published on 04 Nov 2024

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

in Thoracic Oncology

  • Anna Tanaka
  • Shuhei Teranishi
  • Yukihito Kajita
  • Tomofumi Hirose
  • Ayami Kaneko
  • Yu Sairenji
  • Hidetoshi Kawashima
  • Kentaro Yumoto
  • Toshinori Tsukahara
  • Kenji Miura
Frontiers in Oncology
doi 10.3389/fonc.2024.1400277
  • 2,818 views